University Hospital of Bern

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

• Inselspital

  Bern, 3010

  35 trials

• University Hospital Bern

  Bern, 3010

  22 trials

• Inselspital - Universitaetsspital Bern

  Bern, 3010

  17 trials

• Inselspital, Bern University Hospital

  Bern, 3010

  13 trials

• Bern University Hospital

  Bern, 3010

  9 trials

• Inselspital, University Hospital Bern

  Bern, 3010

  9 trials

• Bern University Hospital, Inselspital

  Bern, 3010

  7 trials

• University Hospital Bern / Inselspital

  Bern, 3010

  7 trials

• Universitaetsspital Bern, Inselspital

  Bern, 3010

  6 trials

• University Hospital of Bern

  Bern, 3010

  6 trials

• Department of Cardiology, University Hospital Bern, Inselspital, Bern

  Bern, 3010

  3 trials

  • NCT04827316Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT)

    Contact: Christoph Gräni, Prof

  • NCT04774549Inflammatory Cardiomyopathy Bern Registry

  • NCT04776824Swiss Cardiac Amyloidosis REgistry (Swiss-CARE)

    Contact: Christoph Gräni, Prof

• Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, Bern University Hospital

  Bern, 3010

  3 trials

  • NCT05997771A Personal Nutrition Advisor to Assist Remote Dietary Counselling for Weight Loss and Maintenance

  • NCT05392452Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)

  • NCT04788836How Altered Gut-Brain-Axis Influences Food Choices: Part 2 (BrainFood)

• Dep. of Neurosurgery, Bern University Hospital

  Bern, 3010

  3 trials

  • NCT07616986LITT for Ultra-early GBM Recurrence

    Contact: Alexis Terrapon, MD

  • NCT05204472Thalamic-Burst-DBS for Neuropathic Pain

    Contact: Andreas Nowacki, MD

  • NCT02394626Surgery for Recurrent Glioblastoma

    Contact: Philippe Schucht (principal investigator)

• University Hospital of Bern (Inselspital)

  Bern, 3010

  3 trials

  • NCT06561919STIMPulseControl Ancillary Speech Study

    Contact: Ines Debove, MD

  • NCT06498349Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl

    Contact: Ines Deboves, MD

  • NCT05357781Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?

    Contact: Lara Diem, MD

• Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University Hospital

  Bern, Canton of Bern 3010

  2 trials

  • NCT07478211Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery

  • NCT05671679Supporting Meal Management in Type 1 Diabetes

• Department of Paediatrics, Inselspital, Bern University Hospital

  Bern, 3010

  2 trials

  • NCT06311162Early Life Intervention in Pediatrics Supported by E-health - SMOKE

    Contact: Julian Jakob, MD

  • NCT06208345Early Life Intervention in Pediatrics Supported by E-health

    Contact: Christoph Saner, PhD, MD

• Inselspital, Bern University Hospital, Department of Cardiology

  Bern, 3010

  2 trials

  • NCT05955365Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

    Contact: Stephan Windecker, Prof

  • NCT04870424Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

• Inselspital - Inselspital

  Bern, 3010

  2 trials

  • NCT05815927Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer

    Contact: EORTC HQ

  • NCT06462963OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)

    Contact: EORTC HQ

• Inselspital - Universitaetsspital Bern - Neuropsychologische Rehabilitation, Neurologie

  Bern, 3010

  2 trials

  • NCT06463587Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

    Contact: Robert Hoepner (principal investigator)

  • NCT04934800Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

• Inselspital, Universitätsspital

  Bern

  2 trials

  • NCT04742361Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

  • NCT03417011FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System

• Universitatklinik fur Medizinische Onkologie, Inselspital

  Bern, 3010

  2 trials

  • NCT04214210The DIALOGUE Study: Swiss-Korean Billateral Collaboration

  • NCT03124212Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland

    Contact: Manuela Rabaglio, MD

• Universitätsklinik für Medizinische Onkologie, Inselspital

  Bern, 3010

  2 trials

  • NCT05601973Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI

  • NCT04111978MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

    Contact: Julian Wampfler, MD PhD

• Universitätsspital Bern, Inselspital

  Bern, 3010

  2 trials

  • NCT06963203Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis

    Contact: Reto Kaderli, Prof.

  • NCT03945773Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors

• Bern University Hospital, Dep. of Cardiology

  Bern, 3010

  1 trial

  • NCT05711186Structured Shared Decision Making for Patients Undergoing SAVR or TAVR

    Contact: Thomas Pilgrim, Prof.

• Bern University Hospital, Inselspital Bern

  Bern

  1 trial

  • NCT07276282Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction

    Contact: Lorenz Räber, MD, PhD

• Centre for Rehabilitation & Sports Medicine, Inselspital, University Hospital of Bern, Bern Switzerland

  Bern

  1 trial

  • NCT07252856Transcultural Digital Solutions in Phase III Cardiac Rehabilitation

    Contact: Matthias Wilhelm

• Department of Anaesthesiology and Pain Medicine, Bern University Hospital, University of Bern

  Bern, 3010

  1 trial

  • NCT04828226Clonidine to Prevent Delirium After Electroconvulsive Therapy.

• Department of Cardiology, Bern University Hospital

  Bern, 3010

  1 trial

  • NCT05732701Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions

    Contact: Miklos Rohla, MD, PhD (principal investigator)

• Department of Cardiology, Inselspital, Bern University Hospital, University of Bern

  Bern

  1 trial

  • NCT07815171Lattice vs Pentaspline Comparative Evaluation in Persistent AF

    Contact: Tobias Reichlin

• Department of Neurology, Inselspital

  Bern, 3010

  1 trial

  • NCT06659120Fremanezumab for the Prevention of Menstrually-related Migraine Attacks

    Contact: Christoph J Schankin, Prof

• Department of Neurology, Inselspital, University Hospital Bern, University of Bern

  Bern, 3010

  1 trial

  • NCT05653141Post-stroke Cognitive Impairment

    Contact: Roza M. Umarova, PD Dr.

• Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Inselspital, Bern University Hospital

  Bern, 3010

  1 trial

  • NCT05894070The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer

    Contact: Roland Giger, Prof.

• Department of Oto-Rhino-Laryngology, Head and Neck surgery Inselspital, Bern University Hospital and University of Bern

  Bern, 3010

  1 trial

  • NCT07102264Safety & Feasibility of Ultrasound-assisted Non-invasive Measurement of Compressibility of the Thyroid Gland in Patients Scheduled for Surgical Removal

    Contact: PD Dr. med. Urs Borner

• Dep. of Neurology / Dep. of Neurosurgery, Bern University Hospital

  Bern, 3010

  1 trial

  • NCT02258919Decompressive Hemicraniectomy in Intracerebral Hemorrhage

• Dep. Ophthalmology, University Hospital Bern

  Bern, 3010

  1 trial

  • NCT00564291Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)

• Dept, of Neurology, Inselspital, University of Bern

  Bern, 3010

  1 trial

  • NCT06100718Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study

    Contact: Simon Jung, MD

• Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital

  Bern, 3010

  1 trial

  • NCT03880162Metabolic Effects of a Low Carbohydrate Versus a Standard Diet in Morbidly Obese With Prediabetes

• Div. of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital

  Bern, 3010

  1 trial

  • NCT01039922SwissNET - a Registry for Neuroendocrine Tumours in Switzerland

• Inselgruppe AG, Inselspital

  Bern, 3010

  1 trial

  • NCT05746806Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy

• Inselspital Bern (Inselspital, Universitatsspital Bern)

  Bern, 3010

  1 trial

  • NCT06973187A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Contact: Study Director

• Inselspital, Bern University Hospital, Universitätsklinik für Radio-Onkologie

  Bern

  1 trial

  • NCT04459715A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

• Inselspital, Department of Dermatology

  Bern, 3010

  1 trial

  • NCT05819463Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland

    Contact: Dagmar Simon, Prof. Dr. med.

• Inselspital, Universitaetsspital Bern /ID# 152602

  Bern, 3010

  1 trial

  • NCT03006068A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

• Inselspital, Universitaetsspital Bern /ID# 163535

  Bern, 3010

  1 trial

  • NCT03105102A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

• Inselspital, Universitaetsspital Bern /ID# 170994

  Bern, 3010

  1 trial

  • NCT03345823A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

• Inselspital, Universitaetsspital Bern /ID# 202909

  Bern, 3010

  1 trial

  • NCT03398135A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis

• Inselspital, Universitaetsspital Bern /ID# 210031

  Bern, 3010

  1 trial

  • NCT03342144Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

    Contact: Johannes Huelsenbeck

• Inselspital, Universitaetsspital Bern /ID# 212741

  Bern, 3010

  1 trial

  • NCT03982394Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

• Inselspital, Universitaetsspital Bern /ID# 223439

  Bern, 3010

  1 trial

  • NCT04468984Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

• Inselspital, Universitaetsspital Bern /ID# 223590

  Bern, 3010

  1 trial

  • NCT04524611Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

• Inselspital, Universitaetsspital Bern /ID# 224951

  Bern, 3010

  1 trial

  • NCT04497597A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis

• Inselspital, Universitaetsspital Bern /ID# 239241

  Bern, 3010

  1 trial

  • NCT05215639A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets

• Inselspital, Universitaetsspital Bern /ID# 250577

  Bern, 3010

  1 trial

  • NCT05601882A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

• Inselspital, Universitaetsspital Bern /ID# 252909

  Bern, 3010

  1 trial

  • NCT05843643Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

• Inselspital, Universitaetsspital Bern /ID# 254736

  Bern, 3010

  1 trial

  • NCT05889182A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

• Inselspital, Universitaetsspital Bern /ID# 255321

  Bern, 3010

  1 trial

  • NCT05995353A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

• Inselspital, Universitaetsspital Bern /ID# 259485

  Bern, 3010

  1 trial

  • NCT05841537An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

• Inselspital, Universitaetsspital Bern /ID# 260106

  Bern, 3010

  1 trial

  • NCT06257875A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

• Inselspital, Universitaetsspital Bern /ID# 260968

  Bern, 3010

  1 trial

  • NCT05496348Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis

• Inselspital, Universitaetsspital Bern /ID# 265733

  Bern, 3010

  1 trial

  • NCT06548542Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

    Contact: Site Coordinator

• Inselspital, Universitaetsspital Bern /ID# 265818

  Bern, 3010

  1 trial

  • NCT06543914Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine

• Inselspital, Universitaetsspital Bern /ID# 273364

  Bern, 3010

  1 trial

  • NCT06880744A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

• Inselspital, Universitaetsspital Bern /ID# 276718

  Bern, 3010

  1 trial

  • NCT07136467A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

    Contact: Beth Rycroft

• Inselspital - Universitatsklinik Bern

  Bern, 3010

  1 trial

  • NCT05131022A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

• Inselspital, Universitätsklinik für Kinderheilkunde

  Bern, CH-3010

  1 trial

  • NCT04221035High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

    Contact: Jochen Rößler, MD

• Inselspital, Universitätspital

  Bern, Switzerland

  1 trial

  • NCT06465498Investigating aCute heArt failuRe Decongestion Guided by Lung UltraSonography

    Contact: Claudio Schneider

• Inselspital, Universitätsspital Bern, Department of Otolaryngology, Head and Neck Surgery, Audiology

  Bern, 3010

  1 trial

  • NCT07777562Retrospective Analysis of Performance and Safety of MED-EL Cochlear Implants.

    Contact: Martin Kompis, Prof. Dr. med. Dr. sc. techn.

• Inselspital, Universitätsspital Bern /ID# 201598

  Bern, 3010

  1 trial

  • NCT03569293Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)

• Inselspital, Universitatsspital Bern, Kinderklinik, Julie-von-Jenner-Haus

  Bern, 3010

  1 trial

  • NCT06100289A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

    Contact: Christiane Sokollik (principal investigator)

• Inselspital, Universitatsspital Bern - Universitatsklinik fur Medizinisch Onkologie

  Bern, CH 3010

  1 trial

  • NCT04778397Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

• Inselspital, Universitätsspital Bern Universitätsklinik für Viszerale chirurgie und Medizin Hepatologie

  Bern, 3010

  1 trial

  • NCT04526665Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

• Inselspital, Universitätsspital; Universitätsklinik für Diabetologie, Endokrinologie, Ernährungsmedizin & Metabolismus (UDEM)

  Bern, Canton of Bern 3010

  1 trial

  • NCT07087340Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis

• Inselspital, University Hospital Bern, Heart Vascular Center

  Bern, Canton Bern CH-3010

  1 trial

  • NCT06332911Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair

    Contact: Prof. Dr. Drosos Kotelis

• Inselspital - University Hospital Bern Site 1

  Bern, 3010

  1 trial

  • NCT06056297A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

    Contact: Patient Affairs and Advocacy

• Inselspital - University Hospital Bern Site 2

  Bern, 3010

  1 trial

  • NCT06056297A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

    Contact: Patient Affairs and Advocacy

• Inselspital, University of Berne, Deparftment of Radio-Oncology

  Bern, 3010

  1 trial

  • NCT06361043Conebeam CT-based Online Adaptive Radio-Therapy for Esophageal Cancer (ARTEC)

    Contact: Hossein Hammatazad, MD

• Insespital, University Hospital Bern

  Bern, 3010

  1 trial

  • NCT06464237Metacognitive Intervention in Youth With Oncological Disease - the Mio Study

    Contact: Regula Everts, Prof. Dr. phil. (principal investigator)

• Preventive Cardiology and Sports Medicine, Bern University Hospital, Inselspital

  Bern, 3010

  1 trial

  • NCT05057884Breathing Exercise Against Dyspnoea in Heart Failure Patients to Improve Chemosensitivity

• Reha Inselspital, Bern University Hospital, Centre for Rehabilitation & Sports Medicine, Insel Group

  Bern, 3010

  1 trial

  • NCT06516172The Bern Rehab Registry

    Contact: Prisca Eser, PhD

• Schlaf-Wach-Epilepsie Zentrum, Inselspital

  Bern

  1 trial

  • NCT04145674A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo

• Universitäre Neurorehabilitation, Inselspital

  Bern, 3010

  1 trial

  • NCT03342534Effect of tDCS on Brain Organization and Motor Recovery

• Universitätsklinik für Kinderheilkunde, Pädiatrische Hämatologie/ Onkologie, Inselspital

  Bern, 3010

  1 trial

  • NCT03206671Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

• Universitätsklinik für Pneumologie, Inselspital

  Bern

  1 trial

  • NCT03984253Swiss Severe Asthma Register

    Contact: Nikolay Pavlov, MD

• University Hospital Bern, Department of Cardiology

  Bern, 3010

  1 trial

  • NCT06559332Coronary Artery Disease Assessment Strategies in TAVI Patients

    Contact: Jonas Lanz, MD, MSc

• University Hospital Bern, Division of Hematology

  Bern

  1 trial

  • NCT04812483Immunomodulation With Eltrombopag in ITP

• University Hospital Bern/Inselspital Bern

  Bern, 3010

  1 trial

  • NCT05819398Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

• University Hospital of Bern, Center of Parkinson's diseases and Movement disorders (ZfPB), Merz investigational site #0410015

  Bern, 3010

  1 trial

  • NCT03992404Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury

• University Hospital of Bern, Department of Gynecological Endocrinology & Reproductive Medicine

  Bern, 3010

  1 trial

  • NCT06497894No More Sleepless Nights in Perimenopause

    Contact: Petra Stute, Prof.